Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Jennewein Biotechnologie GmbH

Jennewein Biotechnologie is a leading international industrial biotechnology company with a range of products in the field of human milk oligosaccharides (HMOs) and rare monosaccharides such as L-Fucose and Sialic acid. The company manufactures an extensive portfolio of innovative HMO products, such as 2' fucosyllactose, 3'-fucosyllactose, Lacto-N-neotetraose, and lacto-N-tetraose. These rare sugars are used in the food industry (particularly infant milk formulas), the pharmaceutical industry, and the cosmetic industry. *


Period Start 2005-01-01 established
  Group Chr. Hansen (Group)
Products Industry human milk oligosaccharides (HMO)
  Industry 2 foods, functional
Persons Person Jennewein, Klaus (Jennewein Biotechnologie GmbH 201512 Managing Director + Co-Founder)
  Person 2 Jennewein, Amélie (Jennewein Biotechnologie GmbH Co-Founder)
Region Region Rheinland-Pfalz (town unspecified)
  Country Germany
  Street 32 Maarweg
  City 53619 Rheinbreitbach
  Tel +49-2224-989-4502
    Address record changed: 2020-12-02
Basic data Employees C: 51 to 100 (2020-09-22)
  Currency EUR
  Annual sales 50 (sales, expected (2021) 2021-12-31)
    * Document for �About Section�: Chr. Hansen Holding A/S. (9/22/20). "Press Release: Chr. Hansen Acquires Jennewein Biotechnologie GmbH to Enter and Lead the High-growth Human Milk Oligosaccharides Market".
Record changed: 2020-09-24


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Chr. Hansen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top